These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
246 related articles for article (PubMed ID: 16205118)
1. Myeloid leukemia-associated nucleophosmin mutants perturb p53-dependent and independent activities of the Arf tumor suppressor protein. den Besten W; Kuo ML; Williams RT; Sherr CJ Cell Cycle; 2005 Nov; 4(11):1593-8. PubMed ID: 16205118 [TBL] [Abstract][Full Text] [Related]
2. Ubiquitination of, and sumoylation by, the Arf tumor suppressor. den Besten W; Kuo ML; Tago K; Williams RT; Sherr CJ Isr Med Assoc J; 2006 Apr; 8(4):249-51. PubMed ID: 16671360 [TBL] [Abstract][Full Text] [Related]
3. Delocalization and destabilization of the Arf tumor suppressor by the leukemia-associated NPM mutant. Colombo E; Martinelli P; Zamponi R; Shing DC; Bonetti P; Luzi L; Volorio S; Bernard L; Pruneri G; Alcalay M; Pelicci PG Cancer Res; 2006 Mar; 66(6):3044-50. PubMed ID: 16540653 [TBL] [Abstract][Full Text] [Related]
4. Nucleophosmin (B23) targets ARF to nucleoli and inhibits its function. Korgaonkar C; Hagen J; Tompkins V; Frazier AA; Allamargot C; Quelle FW; Quelle DE Mol Cell Biol; 2005 Feb; 25(4):1258-71. PubMed ID: 15684379 [TBL] [Abstract][Full Text] [Related]
6. Sumoylation induced by the Arf tumor suppressor: a p53-independent function. Tago K; Chiocca S; Sherr CJ Proc Natl Acad Sci U S A; 2005 May; 102(21):7689-94. PubMed ID: 15897463 [TBL] [Abstract][Full Text] [Related]
7. Reactivating the ARF-p53 axis in AML cells by targeting ULF. Chen D; Yoon JB; Gu W Cell Cycle; 2010 Aug; 9(15):2946-51. PubMed ID: 20699639 [TBL] [Abstract][Full Text] [Related]
8. Physical and functional interactions of the Arf tumor suppressor protein with nucleophosmin/B23. Bertwistle D; Sugimoto M; Sherr CJ Mol Cell Biol; 2004 Feb; 24(3):985-96. PubMed ID: 14729947 [TBL] [Abstract][Full Text] [Related]
10. The leukemia-associated cytoplasmic nucleophosmin mutant is an oncogene with paradoxical functions: Arf inactivation and induction of cellular senescence. Cheng K; Grisendi S; Clohessy JG; Majid S; Bernardi R; Sportoletti P; Pandolfi PP Oncogene; 2007 Nov; 26(53):7391-400. PubMed ID: 17546053 [TBL] [Abstract][Full Text] [Related]
11. AKT regulates NPM dependent ARF localization and p53mut stability in tumors. Hamilton G; Abraham AG; Morton J; Sampson O; Pefani DE; Khoronenkova S; Grawenda A; Papaspyropoulos A; Jamieson N; McKay C; Sansom O; Dianov GL; O'Neill E Oncotarget; 2014 Aug; 5(15):6142-67. PubMed ID: 25071014 [TBL] [Abstract][Full Text] [Related]
12. Cytoplasmic mutated nucleophosmin is stable in primary leukemic cells and in a xenotransplant model of NPMc+ acute myeloid leukemia in SCID mice. Falini B; Martelli MP; Mecucci C; Liso A; Bolli N; Bigerna B; Pucciarini A; Pileri S; Meloni G; Martelli MF; Haferlach T; Schnittger S Haematologica; 2008 May; 93(5):775-9. PubMed ID: 18367491 [TBL] [Abstract][Full Text] [Related]
13. B23 and ARF: friends or foes? Lindström MS; Zhang Y Cell Biochem Biophys; 2006; 46(1):79-90. PubMed ID: 16943625 [TBL] [Abstract][Full Text] [Related]
14. Arf-induced turnover of the nucleolar nucleophosmin-associated SUMO-2/3 protease Senp3. Kuo ML; den Besten W; Thomas MC; Sherr CJ Cell Cycle; 2008 Nov; 7(21):3378-87. PubMed ID: 18948745 [TBL] [Abstract][Full Text] [Related]
15. Nucleophosmin protein expression level, but not threonine 198 phosphorylation, is essential in growth and proliferation. Brady SN; Maggi LB; Winkeler CL; Toso EA; Gwinn AS; Pelletier CL; Weber JD Oncogene; 2009 Sep; 28(36):3209-20. PubMed ID: 19561638 [TBL] [Abstract][Full Text] [Related]
16. ARF function does not require p53 stabilization or Mdm2 relocalization. Korgaonkar C; Zhao L; Modestou M; Quelle DE Mol Cell Biol; 2002 Jan; 22(1):196-206. PubMed ID: 11739734 [TBL] [Abstract][Full Text] [Related]
17. Both carboxy-terminus NES motif and mutated tryptophan(s) are crucial for aberrant nuclear export of nucleophosmin leukemic mutants in NPMc+ AML. Falini B; Bolli N; Shan J; Martelli MP; Liso A; Pucciarini A; Bigerna B; Pasqualucci L; Mannucci R; Rosati R; Gorello P; Diverio D; Roti G; Tiacci E; Cazzaniga G; Biondi A; Schnittger S; Haferlach T; Hiddemann W; Martelli MF; Gu W; Mecucci C; Nicoletti I Blood; 2006 Jun; 107(11):4514-23. PubMed ID: 16455950 [TBL] [Abstract][Full Text] [Related]
18. The cytoplasmic NPM mutant induces myeloproliferation in a transgenic mouse model. Cheng K; Sportoletti P; Ito K; Clohessy JG; Teruya-Feldstein J; Kutok JL; Pandolfi PP Blood; 2010 Apr; 115(16):3341-5. PubMed ID: 19666870 [TBL] [Abstract][Full Text] [Related]